You are here: Industry Insights > AndroGel

News List

Aleor Dermaceuticals gets USFDA Final nod for Testosterone Gel expresspharma
March 04, 2021
Testosterone Gel is indicated for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone.
Teva launches generic AndroGel biospectrumasia
April 22, 2019
Testosterone Gel 1.62% CIII is indicated for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone
AbbVie strikes tentative deal to settle 4,000-plus AndroGel lawsuits fiercepharma
September 12, 2018
Lawyers for AbbVie and AndroGel plaintiffs have reached a potential settlement, Judge Matthew Kennelly wrote in a Monday court filing.
Judge strikes $140M AndroGel verdict after AbbVie appeal fiercepharma
July 09, 2018
Right on the heels of a legal setback relating to AndroGel antitrust claims, AbbVie has scored a reversal of a $140 million verdict in the case of a plaintiff who argued the company's testosterone drug caused his heart attack.